Jeremy Gungabeesoon

@jgungabeesoon

Immuno-oncology @Sanofi | Previously @BBS_Harvard @PittetLab @MGHCSB

Boston, MA Joined March 2018

268 Following 221 Followers 137 Posts

Latest posts 5

Pinned post

Jeremy Gungabeesoon @jgungabeesoon Mar 30, 2023

Excited to share my PhD work in the @PittetLab, published today in @CellCellPress! We show that immunotherapy can expand a distinct interferon-responsive neutrophil state that contributes to successful responses to therapy: sciencedirect.com/science/articl…

The Pittet Lab @PittetLab Mar 30, 2023

❔What is special about an immune system that successfully attacks tumors, compared to one that doesn’t?

Our new study in @CellCellPress led by @jgungabeesoon, @Nich and @Mate_Kiss_ aimed to address this question. A joint work with the great @KleinLabHMS

authors.elsevier.com/a/1gqieL7PXmbtw
View quoted post on X

Jeremy Gungabeesoon @jgungabeesoon Mar 31, 2023

Read more about my PhD work here! @PittetLab @KleinLabHMS

Harvard Medical School Verified account @harvardmed Mar 30, 2023

Neutrophils — the most common cell type in the immune system — play a key role in immunotherapy success hvrd.me/vv3X50Nw2xn
View quoted post on X

Jeremy Gungabeesoon @jgungabeesoon Apr 9, 2019

New study from @PittetLab and Allon Klein in @ImmunityCP: Single-cell transcriptomics shows conservation of specific tumor-infiltrating myeloid (TIM) populations between mouse and human lung cancer! cell.com/immunity/fullt…

Jeremy Gungabeesoon @jgungabeesoon Dec 11, 2018

New paper from the @PittetLab this week in @ImmunityCP - crosstalk between T cells and IL-12-producing DCs is required for effective anti-PD-1 responses! cell.com/immunity/fullt…
Congrats @csgarrix and Sean Arlauckas! @MGHCSB @MGH_RI #Immunotherapy

0:06

Jeremy Gungabeesoon @jgungabeesoon Oct 3, 2018

“I agree that the rule of 3 is not a wise one,” Chen told STAT. “Because of this rule, many scientists spend a lot of time promoting themselves, rather than doing discovery to solve the problem.”

STAT Verified account @statnews Oct 2, 2018

When the #NobelPrize committee announced the medicine winners yesterday, three experts in immunotherapy said they were "shocked" that three scientists who were key to the development of checkpoint inhibitors were overlooked. buff.ly/2y7xPWV
View quoted post on X